Cite
HARVARD Citation
Syed, N. et al. (2015). Silencing of high‐mobility group box 2 (HMGB2) modulates cisplatin and 5‐fluorouracil sensitivity in head and neck squamous cell carcinoma. Proteomics. 15 (2), pp. 383-393. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Syed, N. et al. (2015). Silencing of high‐mobility group box 2 (HMGB2) modulates cisplatin and 5‐fluorouracil sensitivity in head and neck squamous cell carcinoma. Proteomics. 15 (2), pp. 383-393. [Online].